SCHEMBL21472963

SCHEMBL21472963

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c5ccccc5c5ccc6c7ccccc7n7c3c4c5c67)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 2/20 0.35
TSHR P16473 2/20 0.35
KDM4E B2RXH2 2/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
ADORA3 P0DMS8 1/20 0.33
ALOX15 P16050 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
ATM Q13315 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
PDE5A O76074 2/20 0.31
GBA1 P04062 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21472964 0.93 MEN1 (0.35) ACP1TSHRKDM4EHSD17B10L3MBTL1
SCHEMBL21472966 0.89 MEN1 (0.35) TSHRKDM4EHSD17B10L3MBTL1ADORA2A
SCHEMBL21473092 0.88 TSHR (0.35) ACP1TSHRKDM4EHSD17B10L3MBTL1
SCHEMBL21473105 0.86 MEN1 (0.43) ACP1KDM4EHSD17B10L3MBTL1ADORA2A
SCHEMBL21472961 0.86 HPGD (0.41) KDM4EL3MBTL1ADORA2AADORA1MEN1
SCHEMBL21473044 0.85 HSD17B10 (0.35) TSHRKDM4EHSD17B10L3MBTL1MEN1
SCHEMBL23288216 0.84 KDM4E (0.33) ACP1TSHRKDM4EHSD17B10HPGD
SCHEMBL21473095 0.81 CYP1A2 (0.31) ACP1TSHRKDM4EHSD17B10ALOX15
SCHEMBL23288214 0.81 KDM4E (0.39) ACP1TSHRKDM4EHSD17B10L3MBTL1
SCHEMBL21473101 0.81 MEN1 (0.34) ACP1TSHRKDM4EHSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190315759-A1 HOST MATERIALS FOR ELECTROLUMINESCENT DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2019-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190315759-A1 HOST MATERIALS FOR ELECTROLUMINESCENT DEVICES OSBP, OSBP2, OSBPL3 ACP1 3213/4885TSHR 4716/4885KDM4E 4292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.